Rangarajan S, Gudmundsson G, Qiu Z, Foster P L, Goodman M F
Department of Biological Sciences, University of Southern California, Los Angeles 90089-1340, USA.
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):946-51. doi: 10.1073/pnas.94.3.946.
We have investigated a role for Escherichia coli DNA polymerase II (Pol II) in copying chromosomal and episomal DNA in dividing cells in vivo. Forward mutation frequencies and rates were measured at two chromosomal loci, rpoB and gyrA, and base substitution and frameshift mutation frequencies were measured on an F'(lacZ) episome. To amplify any differences in polymerase error rates, methyl-directed mismatch repair was inactivated. When wild-type Pol II (polB+) was replaced on the chromosome by a proofreading-defective Pol II exo- (polBex1), there was a significant increase in mutation frequencies to rifampicin resistance (RifR) (rpoB) and nalidixic acid resistance (NalR) (gyrA). This increased mutagenesis occurred in the presence of an antimutator allele of E. coli DNA polymerase III (Pol III) (dnaE915), but not in the presence of wild-type Pol III (dnaE+), suggesting that Pol II can compete effectively with DnaE915 but not with DnaE+. Sequencing the RifR mutants revealed a G --> A hot spot highly specific to Pol II exo-. Pol II exo- caused a significant increase in the frequency of base substitution and frameshift mutations on F' episomes, even in dnaE+ cells, suggesting that Pol II is able to compete with Pol III for DNA synthesis on F episomes.
我们研究了大肠杆菌DNA聚合酶II(Pol II)在体内分裂细胞中复制染色体DNA和附加体DNA的作用。在两个染色体位点rpoB和gyrA处测量正向突变频率和速率,并在F'(lacZ)附加体上测量碱基替换和移码突变频率。为了放大聚合酶错误率的任何差异,甲基导向错配修复被失活。当染色体上的野生型Pol II(polB+)被校对缺陷型Pol II exo-(polBex1)取代时,对利福平耐药(RifR)(rpoB)和萘啶酸耐药(NalR)(gyrA)的突变频率显著增加。这种诱变增加发生在大肠杆菌DNA聚合酶III(Pol III)的抗突变等位基因(dnaE915)存在的情况下,但在野生型Pol III(dnaE+)存在的情况下则不会,这表明Pol II可以有效地与DnaE915竞争,但不能与DnaE+竞争。对RifR突变体进行测序发现了一个高度特异性于Pol II exo-的G --> A热点。即使在dnaE+细胞中,Pol II exo-也会导致F'附加体上碱基替换和移码突变频率的显著增加,这表明Pol II能够与Pol III竞争F附加体上的DNA合成。